$64.04
-5.20 (-7.51%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
-60.1% upside
Low Target
$16.07
Average Target
$25.56
High Target
$38.64
Current Price
$64.04
Current
$64.04
$64.04
Target
$25.56
$25.56
$16.07
$25.56 avg
$38.64
Scenario Analysis
Bear Case
$16.07
-74.9%
Low target
Base Case
$25.56
-60.1%
Avg target
Bull Case
$38.64
+-39.7%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$151.02
-57.6% from high
52-Week Low
$53.54
+19.6% from low
50-Day SMA
$76.26
-16.0% vs SMA
200-Day SMA
$100.07
-36.0% vs SMA
RSI (14)
69.6
Neutral
Target vs 52W High
$25.56
-83.1% vs high
Next Earnings Report
Nov 18, 2026 · After Market Close
11d
until earnings
EPS Est: $-1.46
Earnings in 11 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |